Nephrology Dialysis Transplantation

This Article Extract FREE Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (10) Request Permissions Disclaimer Google Scholar Articles by Bukoski, R. D. Search for Related Content PubMed PubMed Citation Articles by Bukoski, R. D. Social Bookmarking          What's this?

Nephrol Dial Transplant (2001) 16: 218-221
© 2001 European Renal Association-European Dialysis and Transplant Association

---

Editorial Comments

Dietary Ca²⁺ and blood pressure: evidence that Ca²⁺-sensing receptor activated, sensory nerve dilator activity couples changes in interstitial Ca²⁺ with vascular tone

Richard Dean Bukoski

Cardiovascular Disease Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA

Introduction

It has been more than 20 years since Ayachi [1] showed that feeding Ca²⁺ to the spontaneously hypertensive rat lowers the animal's blood pressure. This finding, along with other seminal observations [2–4], sparked a burst of activity exploring the relationship between dietary Ca²⁺ intake and blood pressure regulation in human and animal models of hypertension. While the question of whether elevated Ca²⁺ intake lowers blood pressure in humans remains controversial [5,6], data showing an inverse correlation between Ca²⁺ intake and blood pressure in several models of hypertension in the rat and dog are consistent [7–11].

Over the past two decades, multiple mechanisms have been postulated to explain how increased Ca²⁺ intake lowers blood pressure. These range from diet-induced suppression of serum levels of calciotropic hormones, including 1,25 (OH)₂ vitamin D₃ and parathyroid hormone [12], to suppression of sympathetic vasoconstrictor tone through modulation of central [7] or peripheral nervous system activity [13]. One hypothesis that emerged held that elevated Ca²⁺ intake reduces blood pressure by increasing serum ionized Ca²⁺ levels, which in turn cause peripheral vasodilation [14]. This idea was based on two observations. One was the finding that feeding rats a high Ca²⁺ diet caused a slight, but significant, increase in serum ionized Ca²⁺ [2,11]. The second was the work of David Bohr and colleagues showing that raising the concentration of Ca²⁺ in the solution bathing isolated arteries caused vasorelaxation [15,16]. The overall hypothesis was generally regarded as untenable, however, because of the discrepancy between the very small changes in serum ionized Ca²⁺ that were observed in animals (0.2 mmol/l) and the large (>2 mmol/l) increases in extracellular Ca²⁺ that were required to induce relaxation of isolated arteries.

Ca²⁺ and vascular relaxation

Over the past few years we have performed a series of studies that demonstrate that isolated mesenteric branch arteries of the rat and mouse undergo nearly complete relaxation when the concentration of extracellular Ca²⁺ in the bathing media is raised from 1 to 2 mmol/l [17,18]. This work represents an important extension beyond previous reports of Ca²⁺-induced relaxation because the relaxation is seen at much lower concentrations of Ca²⁺ than had previously been observed.

Critical to our demonstration of high sensitivity Ca²⁺-induced relaxation was our discovery that the relaxation event is dependent on an intact perivascular sensory nerve network. For example, we have found that extensive dissection of perivascular connective tissue, acute or sub-chronic denervation with ethanolic phenol [17], or chronic sensory denervation [19] all significantly attenuate the relaxation induced by elevation of extracellular Ca²⁺. Moreover, we have found that Ca²⁺-induced relaxation is antagonized by pharmacological manoeuvres that inhibit hyperpolarization-mediated relaxation and specifically by blockers of high conductance potassium–calcium channels [20]. These observations have led to the hypothesis that exposure of the sensory nerve ending to extracellular Ca²⁺ induces the release of a hyperpolarizing vasodilator substance [17].

Interstitial Ca²⁺

The finding that extracellular Ca²⁺ causes significant relaxation between 1 and 2 mmol/l, combined with the demonstration of a periadventitial nerve dependence of the relaxation event, led to our hypothesis that the perivascular sensory nerve network monitors changes in ionized Ca²⁺ in the interstitial fluid compartment of tissues that are involved in transcellular Ca²⁺ movement, i.e. the small bowel, kidney and bone [21]. Thus, an increase in Ca²⁺ in the interstitial space of one of these tissues would be associated with vasodilation, increased regional blood flow and a washout of Ca²⁺ from the tissue compartment. To test this hypothesis, we used an in situ microdialysis method to measure interstitial Ca²⁺ in the intestinal submucosa and the renal cortex under basal conditions and during manipulation of Ca²⁺ homeostasis.

The results of the studies performed with the small intestine showed that the concentration of interstitial Ca²⁺ in the duodenal submucosa changes dynamically as a function of the concentration of Ca²⁺ present in the lumen of the gut, rising from 1.08 to 1.9 mmol/l when Ca²⁺ in the small bowel is raised from 0 to 6 mmol/l [18]. We also found that the level of Ca²⁺ in the duodenal submucosa was sensitive to the feeding status of the animal, ranging from 1.1 mmol/l in the 24-h-fasted rat to 1.45 mmol/l in the free-feeding rat consuming a 1% Ca²⁺ diet. When the kidney was studied we found that the concentration of free Ca²⁺ in the renal cortex was 1.65 mmol/l under basal conditions and increased 35–40% in response to either raising the concentration of Ca²⁺ in the small bowel or after a 1 h infusion of parathyroid hormone [22]. Thus, Ca²⁺ in the interstitial compartment of at least two tissues that contribute significantly to peripheral resistance, and blood pressure regulation varies dynamically over a range that elicits relaxation of isolated arteries.

The sensory nerve Ca²⁺sensing receptor: a potential molecular link

The data discussed above indicates that high sensitivity Ca²⁺-induced relaxation occurs over a physiological concentration range and is sensory nerve dependent. These observations suggest that the sensory nerve network has a mechanism for monitoring the concentration of Ca²⁺ that is present in the surrounding interstitial fluid. Our discovery, in 1996 [23], that dorsal root ganglia, which house the cell bodies of perivascular sensory nerves, and perivascular sensory nerves themselves express a receptor for extracellular Ca²⁺, provides a possible mechanism. The dorsal root ganglion Ca²⁺ receptor is homologous with the Ca²⁺ sensing receptor that was initially described in the parathyroid gland, and has subsequently been localized to a number of tissues including the kidney and brain [25,26]. We have shown that the Ca²⁺ receptor is present in the perivascular nerve network of a variety of rat tissues, including the mesenteric vasculature, intrarenal arteries and cerebral arteries [27]. These observations have led us to propose the hypothesis that changes in interstitial Ca²⁺ in these tissues activate the sensory nerve Ca²⁺ receptor which, through an as yet undefined pathway, results in the release of a transmitter which diffuses to underlying smooth muscle and causes hyperpolarizing vasodilation (Figure 1 and ref. [21]).

View larger version (14K): [in this window] [in a new window]   Fig. 1. Figure llustrating how transcellular Ca2+ movement in the kidney cortex could modulate vascular tone. (a) Interlobular artery branching into an afferent arteriole (AA) and filtering unit including glomerulus, efferent arteriole (EA) and adjacent proximal tubule. Ca2+ in the blood is filtered at the level of the glomerulus and enters urine. Significant absorption of Ca2+ from the urine occurs at the level of the proximal tubule and enters the interstitial fluid compartment (Ca2+-isf), where it would be in contact with nearby blood vessels. (b) An expansion of the area in the rectangle outlined in (a). On the left is an arterial segment containing vascular smooth muscle cells (VSMC) and the surrounding perivascular sensory nerve network. On the right is a proximal tubule. Ca2+ leaving the urine enters the interstitial fluid where it is free to interact with the periadventitial surface of the artery. (c) An expansion of the rectangle outlined in (b). Shown on the left is a section of the artery containing vascular smooth muscle cells (VSMC), while on the right is a sensory nerve. In this model, interstitial Ca2+ is sensed by the Ca2+ receptor, which through an unknown signaling pathway induces the production of a nerve-derived hyperpolarizing relaxing factor (NDHF). NDHF then diffuses to adjacent vascular smooth muscle cells and after activation of a receptor (R) causes opening of iberiotoxin sensitive potassium–calcium channels which result in hyperpolarizing vasodilation. The net effect of an increase in Ca2+ filtered at the glomerulus would thus be an increase in arterial diameter of small arteries in the renal cortex and an increase in blood flow and washout of interstitial Ca2+. In contrast, a decrease in Ca2+ delivery would reduce sensory nerve dilation and increase vascular resistance.

 

Summary and future perspectives

It is now clear that Ca²⁺, over a range of concentrations that can occur in vivo in the small intestine and the kidney, is able to induce sensory nerve-dependent vasorelaxation. This vasodilator pathway could serve to link changes in vessel diameter and local resistance with fluctuations in interstitial Ca²⁺, such as should occur normally in the intestine and kidney after consumption of a Ca²⁺-containing diet, in response to certain drugs, i.e. thiazide diuretics, or under select pathological conditions, i.e. hyperparathyroidism. Ca²⁺-induced dilation could then modulate local blood flow and, in the kidney, could have long-term effects on salt and water homeostasis and blood pressure through mechanisms described by Cowley and Roman [28]. This pathway might serve as the long sought after link between Ca²⁺ intake and vascular function, and, if the sensory nerve Ca²⁺ receptor proves to be the molecular link, this protein might serve as a molecular target for the development of novel antihypertensive vasodilator compounds with regionally specific actions.

Acknowledgments

This work was supported by grants HL54901, HL59868 and HL64761 from the National Institutes of Health.

Notes

Correspondence and offprint requests to: Richard Dean Bukoski, Cardiovascular Disease Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.

References

1. Ayachi S. Increased dietary calcium lowers blood pressure in the spontaneously hypertensive rat. Metabolism1979; 28: 1234–1238[Medline]
2. McCarron DA, Yung NN, Ugoretz BA, Krutzik S. Disturbances of calcium metabolism in the spontaneously hypertensive rat. Hypertension1981; I165–I167
3. McCarron DA, Morris CD, Cole C. Dietary calcium in human hypertension. Science1982; 217: 267–269[Abstract/Free Full Text]
4. Resnick LM, Laragh JH, Sealey JE, Alderman MH. Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium and plasma renin activity. New Engl J Med1983; 309: 888–891[Abstract]
5. Apel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. New Engl J Med1997; 336: 1117–1124[Abstract/Free Full Text]
6. Taubes G. The (political) science of salt. Science1998; 281: 898–901[Free Full Text]
7. Peuler JD, Morgan DA, Mark AL. High calcium diet reduces blood pressure in Dahl salt sensitive rats by neural mechanisms. Hypertension1987; 9: III159–III165
8. Kageyama Y, Bravo EL. Neurohumoral and hemodynamic responses to dietary calcium supplementation in deoxycorticosterone-salt hypertensive dogs. Hypertension1987; 9: III166–III170
9. Kotchen TA, Ott CE, Whitescarver SA, Resnick LM, Gertner JM, Blehschmidt NG. Calcium and calcium regulating hormones in the "prehypertensive" Dahl salt sensitive rat (calcium and salt sensitive hypertension). Am J Hypertension1989; 2: 747–753[ISI][Medline]
10. McCarron DA, Lucas PA, Schneidmann RJ et al. Blood pressure development of the spontaneously hypertensive rat after concurrent manipulations of dietary Ca²⁺ and Na⁺. Relation to intestinal Ca²⁺ fluxes. J Clin Invest1985; 76: 1147–1154
11. Bukoski RD, Xue H, McCarron DA. Mesenteric artery contractile properties during dietary calcium manipulation in spontaneously hypertensive and Wistar Kyoto normotensive rats. Am J Hypertension1989; 2: 440–448[Medline]
12. Bukoski RD, Ishibashi K, Bian K. Vascular actions of calcium regulating hormones. Sem Nephrol1995; 15: 536–549[ISI][Medline]
13. Hatton DC, Scrogin KE, Levine D et al. Dietary calcium modulates blood pressure through alpha1-adrenergic receptors. Am J Physiol1993; 264: F234–F238[Abstract/Free Full Text]
14. McCarron DA. Calcium metabolism and hypertension. Kidney Int1989; 35: 717–736[ISI][Medline]
15. Bohr DF. Vascular smooth muscle: dual effect of calcium. Science1963; 19: 597–599
16. Hollaway ET, Bohr DF. Reactivity of vascular smooth muscle in hypertensive rats. Circ Res1973; 33: 678–685[Abstract/Free Full Text]
17. Bukoski RD, Bian K, Wang Y, Mupanomunda M. Perivascular sensory nerve Ca²⁺ receptor and Ca²⁺-induced relaxation of isolated arteries. Hypertension1997; 30: 1431–1439[Abstract/Free Full Text]
18. Mupanomunda MM, Ishioka N, Bukoski RD. Interstitial Ca²⁺ undergoes dynamic changes over a range that activates the perivascular sensory nerve Ca²⁺ receptor. Am J Physiol1999; 276: H1035–H1042[Abstract/Free Full Text]
19. Mupanomunda MM, Wang Y, Bukoski RD. Effect of chronic sensory denervation on Ca²⁺-induced relaxation of isolated mesenteric resistance arteries. Am J Physiol1998; 274: H1655–H1661[Abstract/Free Full Text]
20. Ishioka N, Bukoski RD. A role for N-arachidonylethanolamine(anandamide) as the mediator of sensory nerve-dependent Ca²⁺-induced relaxation. J Pharmacol Exp Ther1999; 289: 245–250[Abstract/Free Full Text]
21. Bukoski RD. The perivascular sensory nerve Ca²⁺receptor and blood pressure regulation. An hypothesis. Am J Hypertens1998; 11: 1117–1123[ISI][Medline]
22. Mupanomunda MM, Tian B, Bukoski RD. Renal Interstitial Ca²⁺. Am J Physiol2000; 278: F644–F649[Abstract/Free Full Text]
23. Bukoski RD, Bian K, Nemeth EF, Rogers KV, Ekpenyong I. A Ca²⁺-sensing receptor in the perivascular nerve network mediates Ca²⁺-induced relaxation. J Hypertension1996; 14 [Suppl 1]: S78.
24. Brown EM, Gamba G, Riccardi D et al. Cloning and characterization of an extracellular Ca²⁺-sensing receptor from bovine parathyroid. Nature1993; 366: 575–580[Medline]
25. Riccardi D, Park J, Li WS et al. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA1995; 92: 131–135[Abstract/Free Full Text]
26. Ruat M, Molliver ME, Snowman AM, Snyder SM. Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proc Natl Acad Sci USA1995; 92: 3161–3165[Abstract/Free Full Text]
27. Wang Y, Bukoski RD. Differential distribution of the perivascular Ca²⁺ receptor in rat arteries. Br J Pharmacol1998; 125: 1397–1404[ISI][Medline]
28. Cowley AW, Roman RJ. The role of the kidney in hypertension. J Am Med Assoc1996; 275: 1581–1589[ISI][Medline]

CiteULike    Connotea    Del.icio.us    What's this?

This article has been cited by other articles:

				E. M. Awumey, S. K. Hill, D. I. Diz, and R. D. Bukoski Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2363 - H2370. [Abstract] [Full Text] [PDF]

				J. Ohanian, K. M. Gatfield, D. T. Ward, and V. Ohanian Evidence for a functional calcium-sensing receptor that modulates myogenic tone in rat subcutaneous small arteries Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1756 - H1762. [Abstract] [Full Text] [PDF]

				R. D. Bukoski, S. Batkai, Z. Jarai, Y. Wang, L. Offertaler, W. F. Jackson, and G. Kunos CB1 Receptor Antagonist SR141716A Inhibits Ca2+-Induced Relaxation in CB1 Receptor-Deficient Mice Hypertension, February 1, 2002; 39(2): 251 - 257. [Abstract] [Full Text] [PDF]

				R. D. Bukoski, S. Shearin, W. F. Jackson, and M. F. Pamarthi Inhibition of Ca2+-Induced Relaxation by Oxidized Tungsten Wires and Paratungstate J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 343 - 350. [Abstract] [Full Text] [PDF]

This Article Extract FREE Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (10) Request Permissions Disclaimer Google Scholar Articles by Bukoski, R. D. Search for Related Content PubMed PubMed Citation Articles by Bukoski, R. D. Social Bookmarking          What's this?

Online ISSN 1460-2385 - Print ISSN 0931-0509

Copyright © 2008 European Renal Association - European Dialysis and Transplant Assoc

Oxford Journals Oxford University Press

• Site Map
• Privacy Policy
• Frequently Asked Questions

Other Oxford University Press sites: Oxford University Press Oxford Journals Japan American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics